Diagnosing and treating patients well starts with choosing the most precise test. Cardiac PET imaging is the test of choice more often these days when it comes to assessing coronary artery disease, myocardial perfusion, viability and ventricular function in more complex patients. It makes sense clinically, operationally and financially. It also trumps SPECT in many ways, and can even play a role in cardiac disease prevention.
 

Soon, payers will reward cost-effective, high-quality procedures, while both healthcare providers and patients increasingly will demand efficient, diagnostically accurate nuclear cardiology procedures with low radiation exposure.

At Brigham and Women’s Hospital, like many hospitals and medical centers across the country, cardiac PET is emerging as the go-to imaging modality for a growing list of clinical scenarios.

Experts recently offered a blueprint to make the choice easier when it comes to using cardiac PET to assess coronary artery disease, myocardial perfusion, viability, and ventricular function.